Lamotrigine Tablet, Extended Release — FDA Drug Shortage

To Be Discontinued — Par Health, Inc.

The FDA lists a drug shortage record for Lamotrigine Tablet, Extended Release (tablet) from Par Health, Inc. with status To Be Discontinued. The shortage was first posted on Apr 29, 2026.

Shortage details

Status
To Be Discontinued
Company
Par Health, Inc.
Package NDC
49884-604-11
Dosage Form
Tablet
Presentation
Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)
Initial Posting
Apr 29, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.